Also, it will be important to understand how the FXR/SIRT1 regulatory network isdysregulated in metabolic disease states which likely involves altered cellularkinase signaling pathways that post-transcriptionally affect SIRT1 and FXRlevels and activities. This evidence concerns the gene SIRT1 and metabolic disease.